Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 8-K (Current Report)
Date: January 27, 1999
Reporting Period: Fourth Quarter and Full Year ended December 31, 1998
This filing reports DuPont's 1998 earnings and highlights significant strategic shifts, including the divestiture of its petroleum business (Conoco) and coal operations, alongside the acquisition of Hoechst AG's automotive coatings business.
Key Financial Metrics
| Metric | Q4 1998 | Q4 1997 | Full Year 1998 | Full Year 1997 |
|---|---|---|---|---|
| Sales (Continuing Ops) | $6.10 billion | $5.90 billion | $24.77 billion | $24.09 billion |
| Diluted EPS (Continuing Ops, Underlying) | $0.60 | $0.65 | $2.55 | $2.70 |
| Diluted EPS (Total Company, Reported) | $2.82 | $0.23 | $3.90 | $2.08 |
| After-Tax Operating Income (Continuing Ops, Underlying) | $746 million | $830 million | $3.21 billion | $3.33 billion |
| Net Income | $3.22 billion | $262 million | $4.48 billion | $2.41 billion |
Debt and Liquidity: The filing notes an extraordinary charge of $201 million (after-tax) in 1998 for the early extinguishment of debt with an aggregate principal amount of $1,633 million. The filing text does not provide specific total debt or liquidity ratios for the period.
Material Changes vs. Prior Period
- Earnings Decline (Underlying): Full-year underlying diluted earnings per share from continuing operations decreased 6% to $2.55, driven by a challenging economic environment, downward price pressure, and a $0.15 per share negative currency impact.
- Reported Earnings Surge: Reported earnings for Q4 1998 ($2.82/share) and Full Year 1998 ($3.90/share) were significantly higher than 1997 due to nonrecurring gains, primarily a $2.13 per share gain from the Conoco IPO and the sale of coal operations.
- Segment Performance:
- Chemicals: Earnings up 12% to $662 million; sales down 4% due to volume declines.
- Fibers: Earnings down 12% to $843 million; sales down 5% due to competitive pressures on "Dacron" and "Lycra."
- Life Sciences: Earnings down 17% to $500 million; sales up 33% due to acquisitions (DuPont Merck buyout).
- Discontinued Operations: Income from discontinued operations (Conoco) dropped 38% on an underlying basis due to lower oil and gas prices, but reported income surged due to the gain on disposal.
Guidance, Outlook, and Risks
Management Commentary: CEO Charles O. Holliday, Jr. expressed disappointment with the 6% decline in underlying earnings after four years of records but remains undiscouraged. He noted that nearly half of business units increased earnings year-over-year.
Outlook: Management anticipates several more quarters of low volume growth and continued price pressure. They expect lower raw material costs and favorable currency comparisons to help weather the cycle.
Risks and Contingencies:
- Market Conditions: Continued downward pressure on selling prices and low volume growth globally.
- Currency: Negative currency impacts in 1998; future results depend on favorable currency comparisons.
- Divestiture Timeline: The Company intends to complete the tax-free split-off of remaining Conoco shares to shareholders by the third quarter of 1999.
Investor Verification Checklist
- Conoco Divestiture Status: Verify the timeline and tax implications of the remaining 69.5% Conoco split-off scheduled for Q3 1999.
- Underlying vs. Reported Earnings: Confirm the sustainability of earnings excluding the one-time $2.13 per share gain from the Conoco IPO and coal sale.
- Segment Margins: Analyze the specific drivers of the 12% earnings decline in the Fibers segment and the 17% decline in Life Sciences.
- Acquisition Integration: Review the financial impact of the $1.9 billion acquisition of Herberts (Hoechst AG automotive coatings) and the full consolidation of DuPont Merck Pharmaceuticals.
- Debt Reduction: Assess the impact of the $1.63 billion debt extinguishment on future interest expenses and leverage ratios.